• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期咖啡因暴露期间咖啡因和腺苷激动剂的行为特征

Behavioral characterization of caffeine and adenosine agonists during chronic caffeine exposure.

作者信息

Newland M C, Brown K

机构信息

Department of Psychology, Auburn University, AL 36849, USA.

出版信息

Behav Pharmacol. 1997 Feb;8(1):17-30.

PMID:9832997
Abstract

Many of the behavioral actions of caffeine are mediated by its blockade of adenosine receptors, a notion that may have implications for tolerance and supersensitivity associated with chronic caffeine exposure. To examine possible interactions between chronic caffeine and adenosine-related actions of several drugs, the acute effects of caffeine and three adenosine agonists on behavior maintained by a Multiple Fixed-Interval (FI), Duration > 5 s schedule of reinforcement were studied using rats chronically consuming either 0 (tap water control), 0.5 mg/ml, or 1.0 mg/ml of caffeine in their drinking water. 5'-(N-cyclopropyl)-carboxamidoadenosine [CPCA (preferential A2 agonist)], 5'-N-ethylcarboxamidoadenosine [NECA (about equal agonist activity at A1 and A2 receptors)], and R(-)N6-(2-phenylisopropyl)adenosine [R-PIA (preferential A1 agonist)], as well as caffeine (nonspecific adenosine antagonist), were administered acutely i.p. after behavior stabilized. Dose-related decreases in overall response rate were produced by all adenosine agonists. Acute administration of all adenosine agonists and higher doses of caffeine increased average lever-press durations under the FI schedule from about 0.3 s to between 1 and 3 s, a three- to 10-fold increase. CPCA and NECA were 10 times more potent than R-PIA on all measures. Caffeine increased overall response rate under the FI schedule at doses of 3-30 mg/kg in nontolerant rats, and decreased rates at higher doses, which also increased lever-press durations. Insurmountable tolerance was seen to the rate-increasing effects of caffeine on behavior under the FI schedule, in rats exposed chronically to caffeine. Modest evidence of surmountable tolerance was seen in the rate-decreasing effects on the Duration > 5 s schedule. No tolerance to increases in lever-press durations or decreases in response rates was detected. Chronic exposure to caffeine did not alter the acute effects of the adenosine agonists: on all measures and with all adenosine agonists, the dose-effect curves for the three caffeine-exposure groups were indistinguishable from one another. The relative potencies suggest that the acute actions of adenosine agonists are related to A2 receptors. This is consistent with the failure to detect supersensitivity, since upregulation associated with chronic caffeine exposure appears primarily in A1 receptors.

摘要

咖啡因的许多行为作用是由其对腺苷受体的阻断介导的,这一观点可能与慢性咖啡因暴露相关的耐受性和超敏反应有关。为了研究慢性咖啡因与几种药物的腺苷相关作用之间可能的相互作用,使用长期饮用含0(自来水对照)、0.5mg/ml或1.0mg/ml咖啡因的大鼠,研究了咖啡因和三种腺苷激动剂对由多重固定间隔(FI)、持续时间>5秒强化程序维持的行为的急性影响。在行为稳定后,腹腔注射5'-(N-环丙基)-羧酰胺腺苷[CPCA(优先A2激动剂)]、5'-N-乙基羧酰胺腺苷[NECA(在A1和A2受体上具有大致相等的激动剂活性)]和R(-)N6-(2-苯异丙基)腺苷[R-PIA(优先A1激动剂)],以及咖啡因(非特异性腺苷拮抗剂)。所有腺苷激动剂均产生与剂量相关的总体反应率下降。所有腺苷激动剂和较高剂量的咖啡因急性给药后,在FI程序下平均杠杆按压持续时间从约0.3秒增加到1至3秒之间,增加了三到十倍。在所有测量指标上,CPCA和NECA的效力比R-PIA强10倍。在非耐受大鼠中,咖啡因在3-30mg/kg剂量下增加了FI程序下的总体反应率,而在更高剂量下降低了反应率,这也增加了杠杆按压持续时间。在长期暴露于咖啡因的大鼠中,观察到咖啡因对FI程序下行为的速率增加作用产生了不可克服的耐受性。在对持续时间>5秒程序的速率降低作用中,观察到了适度的可克服耐受性证据。未检测到对杠杆按压持续时间增加或反应率降低的耐受性。慢性咖啡因暴露并未改变腺苷激动剂的急性作用:在所有测量指标上以及使用所有腺苷激动剂时,三个咖啡因暴露组的剂量-效应曲线彼此无差异。相对效力表明腺苷激动剂的急性作用与A2受体有关。这与未检测到超敏反应一致,因为与慢性咖啡因暴露相关的上调主要出现在A1受体中。

相似文献

1
Behavioral characterization of caffeine and adenosine agonists during chronic caffeine exposure.长期咖啡因暴露期间咖啡因和腺苷激动剂的行为特征
Behav Pharmacol. 1997 Feb;8(1):17-30.
2
Quantifying the molecular structure of behavior: separate effects of caffeine, cocaine, and adenosine agonists on interresponse times and lever-press durations.量化行为的分子结构:咖啡因、可卡因和腺苷激动剂对反应间隔时间和杠杆按压持续时间的不同影响。
Behav Pharmacol. 1997 Feb;8(1):1-16.
3
Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys.食蟹猴体内腺苷类似物的行为及心血管效应
J Pharmacol Exp Ther. 1987 Apr;241(1):76-83.
4
Behavioral effects of caffeine, N6-(L-phenylisopropyl) adenosine and their combination in the squirrel monkey.咖啡因、N6-(L-苯异丙基)腺苷及其组合对松鼠猴的行为影响。
J Pharmacol Exp Ther. 1984 Dec;231(3):665-70.
5
Role of adenosine receptors in caffeine tolerance.腺苷受体在咖啡因耐受性中的作用。
J Pharmacol Exp Ther. 1991 Jan;256(1):62-8.
6
Effects of adenosine analogs alone and in combination with caffeine in the squirrel monkey.腺苷类似物单独及与咖啡因联合应用对松鼠猴的影响。
Pharmacol Biochem Behav. 1988 Feb;29(2):429-32. doi: 10.1016/0091-3057(88)90181-5.
7
Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys.甲基黄嘌呤和腺苷类似物对松鼠猴中氯氮卓行为效应的调节作用。
J Pharmacol Exp Ther. 1985 Dec;235(3):724-8.
8
Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.在自发性高血压大鼠中重复给予选择性腺苷A1和A2受体激动剂:对A1介导的血流动力学效应产生耐受性。
J Pharmacol Exp Ther. 1994 Mar;268(3):1506-11.
9
Discriminative-stimulus effects of adenosine analogs: mediation by adenosine A2 receptors.腺苷类似物的辨别刺激效应:由腺苷A2受体介导。
J Pharmacol Exp Ther. 1988 Aug;246(2):610-8.
10
Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.腺苷A1和A2A受体参与大鼠体内可卡因和甲基苯丙胺辨别刺激效应的腺苷能调节作用。
J Pharmacol Exp Ther. 2003 Dec;307(3):977-86. doi: 10.1124/jpet.103.056762. Epub 2003 Oct 13.

引用本文的文献

1
Brain activity during a working memory task after daily caffeine intake and caffeine withdrawal: a randomized double-blind placebo-controlled trial.每日摄入咖啡因和戒断咖啡因后进行工作记忆任务时的大脑活动:一项随机、双盲、安慰剂对照试验。
Sci Rep. 2023 Jan 18;13(1):1002. doi: 10.1038/s41598-022-26808-5.